Literature DB >> 15888291

Leishmania chagasi: the alpha-tubulin intercoding region results in constant levels of mRNA abundance despite protein synthesis inhibition and growth state.

Jay E Purdy1, John E Donelson, Mary E Wilson.   

Abstract

The intercoding regions of many Leishmania sp. genes have been implicated in the regulation of mRNA processing, stability, and translation. Herein we show that the intercoding region of the Leishmania chagasi alpha-tubulin gene (alpha-TUB) confers stable beta-galactosidase (beta-GAL) reporter mRNA levels during promastigote growth and development in vitro and during protein synthesis inhibition. The abundance of both endogenous alpha-TUB mRNA and beta-GAL mRNA from a beta-GAL coding region situated upstream of the alpha-TUB intercoding region did not change significantly as promastigotes grew from logarithmic to stationary phase in vitro and the half-life of the beta-GAL mRNA remained constant. The abundance of both the endogenous alpha-TUB and the beta-GAL mRNA increased by less than 2-fold after protein synthesis inhibition corresponding to a moderate increase in mRNA half-life. These data suggest that the alpha-TUB intercoding region is an excellent control for the study of the regulation of other differentially expressed genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888291     DOI: 10.1016/j.exppara.2005.02.008

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

1.  Leishmania chagasi: a tetracycline-inducible cell line driven by T7 RNA polymerase.

Authors:  Chaoqun Yao; Jiwen Luo; Chia-Hung Christine Hsiao; John E Donelson; Mary E Wilson
Journal:  Exp Parasitol       Date:  2007-01-19       Impact factor: 2.011

2.  Identification of the HSP70-II gene in Leishmania braziliensis HSP70 locus: genomic organization and UTRs characterization.

Authors:  César A Ramírez; José M Requena; Concepción J Puerta
Journal:  Parasit Vectors       Date:  2011-08-26       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.